Abstract

Aims: The proinflammatory milieu in cancer patients may expose them to increased risk for acute kidney injury (AKI) after IV contrast (CON). The aims of this study were to determine: (1) the rates of AKI after CON and noncontrast (NC) CT scans in cancer inpatients, (2) if rates differed among cancer subtypes, and (3) whether recent chemotherapy, comorbid conditions, or nephrotoxins increase AKI after CON. Materials and methods: Retrospective data was collected on adults who had received a CON or NC CT from January 1, 2012 to December 30, 2014. AKI was defined as a > 1.5× increased baseline creatinine. Data was analyzed using Rao-Scott χ2-test, propensity score matching, and logistic regressions. Results: A total of 7,512 CT scans were performed in 4,456 patients (4,958 NC, 2,554 CON). The rate for AKI with CON was 7.3% and 11.4% (p < 0.001) with NC imaging. The risk of AKI increased with lower baseline eGFR: for eGFR ≤ 29 mL/min/1.73m2, OR = 1.83 (p = 0.0002); for eGFR 30 – 59 mL/min/1.73m2, OR = 1.5 compared to eGFR ≥ 60 mL/min/1.73m2 (p < 0.0001). AKI rates were higher when any chemotherapy was given within 60 days of CT (OR = 1.22, p < 0.02), with congestive heart failure (OR 1.51, p = 0.0006), and history of AKI (OR 3.89, p < 0.0001). In 1:1 propensity score matched samples, the OR for AKI after CON was 0.87 (p = 0.23) compared to NC. Conclusion: In cancer patients, eGFR below 59 mL/min/1.73m2 were associated with increased rate of AKI, independent of contrast exposure. Congestive heart failure and prior AKI were also associated with increased rates of AKI.

Highlights

  • Among cancer patients, understanding the frequency and risk factors for acute kidney injury (AKI) after IV contrast (CON) is important since these patients rely on imaging studies with CON for diagnosis and staging of disease, to monitor response to treatment, and for surveillance for disease recurrence

  • Recent large retrospective data base analyses in noncancer patients have brought into question whether contrast-induced nephropathy even exists, given that the reported rates of AKI following CON are similar to the basal rate of AKI observed in hospitalized patients [14, 15]

  • Akin to data in noncancer cohorts [16, 17, 18], our analysis showed that AKI was significantly associated with overall lower baseline eGFR, independent of contrast exposure

Read more

Summary

Introduction

Among cancer patients, understanding the frequency and risk factors for acute kidney injury (AKI) after IV contrast (CON) is important since these patients rely on imaging studies with CON for diagnosis and staging of disease, to monitor response to treatment, and for surveillance for disease recurrence. A recent observational study in a cancer cohort suggests that CON is an independent risk factor for AKI [4]. This raises the possibility that AKI after CON may have different pathogeneses and frequencies among cancer and noncancer patients

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call